PMC:7534795 / 4730-4995 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T44","span":{"begin":67,"end":75},"obj":"Disease"},{"id":"T45","span":{"begin":247,"end":255},"obj":"Disease"}],"attributes":[{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"oposed pharmacological agents with potential beneficial effects in COVID-19 patients.\nPharmacological intervention Conclusion Reference\nAntioxidants including Vitamin C and E • Antioxidant effects may ameliorate cardiac injuries of critically ill COVID-19 patients "}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T35","span":{"begin":159,"end":168},"obj":"Chemical"},{"id":"T38","span":{"begin":159,"end":166},"obj":"Chemical"}],"attributes":[{"id":"A35","pred":"chebi_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/CHEBI_21241"},{"id":"A36","pred":"chebi_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/CHEBI_29073"},{"id":"A37","pred":"chebi_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/CHEBI_38290"},{"id":"A38","pred":"chebi_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/CHEBI_33229"}],"text":"oposed pharmacological agents with potential beneficial effects in COVID-19 patients.\nPharmacological intervention Conclusion Reference\nAntioxidants including Vitamin C and E • Antioxidant effects may ameliorate cardiac injuries of critically ill COVID-19 patients "}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T26","span":{"begin":86,"end":135},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"oposed pharmacological agents with potential beneficial effects in COVID-19 patients.\nPharmacological intervention Conclusion Reference\nAntioxidants including Vitamin C and E • Antioxidant effects may ameliorate cardiac injuries of critically ill COVID-19 patients "}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"177","span":{"begin":256,"end":264},"obj":"Species"},{"id":"181","span":{"begin":159,"end":168},"obj":"Chemical"},{"id":"183","span":{"begin":212,"end":228},"obj":"Disease"},{"id":"184","span":{"begin":232,"end":246},"obj":"Disease"},{"id":"185","span":{"begin":247,"end":255},"obj":"Disease"},{"id":"208","span":{"begin":76,"end":84},"obj":"Species"},{"id":"209","span":{"begin":67,"end":75},"obj":"Disease"}],"attributes":[{"id":"A177","pred":"tao:has_database_id","subj":"177","obj":"Tax:9606"},{"id":"A181","pred":"tao:has_database_id","subj":"181","obj":"MESH:D001205"},{"id":"A183","pred":"tao:has_database_id","subj":"183","obj":"MESH:D006331"},{"id":"A184","pred":"tao:has_database_id","subj":"184","obj":"MESH:D016638"},{"id":"A185","pred":"tao:has_database_id","subj":"185","obj":"MESH:C000657245"},{"id":"A208","pred":"tao:has_database_id","subj":"208","obj":"Tax:9606"},{"id":"A209","pred":"tao:has_database_id","subj":"209","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"oposed pharmacological agents with potential beneficial effects in COVID-19 patients.\nPharmacological intervention Conclusion Reference\nAntioxidants including Vitamin C and E • Antioxidant effects may ameliorate cardiac injuries of critically ill COVID-19 patients "}